0001209191-18-048821.txt : 20180829 0001209191-18-048821.hdr.sgml : 20180829 20180829170130 ACCESSION NUMBER: 0001209191-18-048821 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180827 FILED AS OF DATE: 20180829 DATE AS OF CHANGE: 20180829 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAUDLIN TIMOTHY I CENTRAL INDEX KEY: 0001115047 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38034 FILM NUMBER: 181044874 MAIL ADDRESS: STREET 1: C/O SUCAMPO PHARMACEUTICALS, INC. STREET 2: 4520 EAST-WEST HIGHWAY, 3RD FLOOR CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alteryx, Inc. CENTRAL INDEX KEY: 0001689923 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 900673106 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3345 MICHELSON DRIVE STREET 2: SUITE 400 CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: (888) 836-4274 MAIL ADDRESS: STREET 1: 3345 MICHELSON DRIVE STREET 2: SUITE 400 CITY: IRVINE STATE: CA ZIP: 92612 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-08-27 0 0001689923 Alteryx, Inc. AYX 0001115047 MAUDLIN TIMOTHY I C/O ALTERYX, INC. 3345 MICHELSON DRIVE, SUITE 400 IRVINE CA 92612 1 0 0 0 Class A Common Stock 2018-08-27 4 C 0 9286 0.00 A 24095 D Class A Common Stock 2018-08-27 4 S 0 20000 55.67 D 4095 D Stock Option (Right to Buy) 11.88 2018-08-27 4 M 0 9286 0.00 D 2018-01-05 2025-12-19 Class B Common Stock 9286 123370 D Class B Common Stock 0.00 2018-08-27 4 M 0 9286 0.00 A Class A Common Stock 9286 9286 D Class B Common Stock 0.00 2018-08-27 4 C 0 9286 0.00 D Class A Common Stock 9286 0 D Each share of Class B Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class A Common Stock. In addition, each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class B Common Stock have no expiration date. Includes 4,095 shares subject to an award of restricted stock units which shall fully vest on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) June 13, 2019, in each case, so long as the non-employee director continues to provide services to the Issuer through such date. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement for no consideration. Shares of the Issuer's Class A Common Stock will be delivered to the Reporting Person following vesting. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.50 to $56.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Each share of Class B Common Stock will convert automatically into one (1) share of Class A Common Stock upon the earliest to occur of the following: (a) the date specified by a vote of the holders of 66 2/3% of the outstanding shares of Class B Common Stock, (b) March 23, 2027, and (c) the date the shares of Class B Common Stock cease to represent at least 10% of all outstanding shares of Common Stock. The shares of Class A Common Stock and Class B Common Stock have no expiration date. /s/ Christopher M. Lal, by power of attorney 2018-08-29